Pregnancy: Not suitable for pregnant women
In STEP 1, 40% of semaglutide patients and 26% of placebo patients achieved this threshold (OR = 2.46 [95% CI, 1.90 to 3.18]) and in STEP 2, 35% of semaglutide patients and 23% of placebo patients achieved this threshold (OR = 1.73 [95% CI, 1.20 to 2.49])
Given that EV recovery rates are low, their use in drug delivery may be even more expensive than Provenge
Vitamin C is one of the body's most potent antioxidants
Plus, capture your incredible transformation with our Journey Card, because when you're changing this fast, you'll want to remember every milestone
Our comprehensive program includes your initial medical evaluation, the tirzepatide medication, and crucial ongoing support and monitoring from our clinical team